1 completed. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
Follow Stephen M. Strittmatter: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Tolerability of AZD0530 (Saracatinib) in Alzheimer's Disease saracatinib, Placebo - Alzheimer's Disease | Phase 1 | Completed | Stephen M. Strittmatter | 24 | 2013-07-01 | 2021-04-23 |
saracatinib (1)
United States (1)
Christopher van Dyck, MD (1) · Haakon B Nygaard, MD, PhD (1) · Stephen M Strittmatter, MD, PhD (1)
1UH2TR000967-01 (1), R01NS084911 (1)